Related Experiment Video

Updated: Aug 22, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Prospects of genetic research of mild cognitive impairment

C M van Duijn1

  • 1Genetic Epidemiology Unit, Department of Epidemiology and Biostatistics, Erasmus MC, PO Box 1738, Rotterdam, The Netherlands. c.vanduijn@erasmusmc.nl

Journal of Internal Medicine
|August 25, 2004
PubMed

Insights

Genetic research is crucial for understanding mild cognitive impairment (MCI) and its progression to dementia. Further studies on genes, including apolipoprotein E 4, are needed to improve MCI diagnostics and prognostics.

Area of Science:

  • Neuroscience
  • Genetics
  • Gerontology

Background:

  • Mild cognitive impairment (MCI) is a prevalent condition in aging populations.
  • MCI often progresses to Alzheimer's disease (AD) and other dementias, highlighting a genetic link.
  • Current understanding of MCI genetics is limited, necessitating further investigation.

Purpose of the Study:

  • To explore the role of genetic research in improving diagnostic and prognostic tools for MCI.
  • To investigate the genetic overlap between MCI, Alzheimer's disease, and general dementia.
  • To identify new genes associated with MCI risk and progression.

Main Methods:

  • Reviewing existing genetic research on MCI and AD.
  • Proposing follow-up studies on carriers of known AD-related mutations, such as apolipoprotein E 4.
  • Emphasizing the need for large-scale, carefully designed candidate gene studies.

Main Results:

  • Genetic research offers potential for enhanced MCI diagnostic and prognostic tools.
  • Studies on AD mutation carriers may provide insights into MCI.
  • Apolipoprotein E 4 allele carriers warrant further investigation.

Conclusions:

  • The genetics of MCI are intrinsically linked to those of AD and dementia.
  • Continued and robust genetic research is essential for advancing MCI understanding and management.
  • Discovering novel genes is critical for improving outcomes for individuals with MCI.

More Related Videos

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease09:38

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...